| Autor: |
Kim, Min Hwan, Jung, Woon Jung, Jeong, Hyeon Jin, Lee, Kyongkyu, Kil, Hee Seup, Chung, Wee Sup, Nam, Kyung Rok, Lee, Yong Jin, Lee, Kyo Chul, Lim, Sang Moo, Chi, Dae Yoon |
| Zdroj: |
Bulletin of the Korean Chemical Society; June 2022, Vol. 43 Issue: 6 p859-867, 9p |
| Abstrakt: |
We investigated the off‐target binding of amyloid‐beta (Aβ) target [18F]florapronol ([18F]FC119S) using postmortem Alzheimer's disease (AD) brain tissue, compared with a known Aβ target imaging agent, [125I]TZDM and tau targeting [125I]MK as positive and negative controls, respectively. Off‐target binding of monoamine oxidase‐A and ‐B (MAO‐A and ‐B) was screened for FC119S and Pittsburgh compound B (PiB). Autoradiography (ARG) was performed to screen the Aβ‐binding potential using human AD postmortem brain tissue sections. Colocalization was quantitatively analyzed by using image analysis software. Pathological analysis was performed for screening of specific binding of amyloid‐beta and phospho‐tau. Amyloid‐beta targeting [18F]FC119S and [125I]TZDM tracers were showed a similar binding pattern in ARG, but [125I]MK was showed a different binding patterns. In the blocking experiment, [18F]FC119S binding was effectively blocked by a cold TZDM compound. FC119S and PiB were not showed specific binding with MAO‐A and MAO‐B. The autoradiographic binding pattern was positively correlated with the Aβ expression. [18F]FC119S specifically targets amyloid beta in the frontal cortex of postmortem brain tissue with Alzheimer's disease by autoradiographic analysis. The binding pattern of [18F]FC119S differs from tau targeting PET tracer, [125I]MK. Thus, [18F]FC119S has no off‐target binding properties to tau as well as no binding affinity to monoamine oxidase‐A and ‐B. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Plný text